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Abstract
Background: Neuroendocrine tumors (NETs) of the ampulla of Vater are rare and difficult to diagnose. We report a
rare case of a small NET of the ampulla of Vater with metastasis to distant lymph nodes.
Case presentation: The patient was a 54-year-old man complaining of epigastric pain and melena. Upper
gastrointestinal endoscopy revealed a bulging papilla with active bleeding, which was diagnosed as a well-
differentiated NET of the ampulla of Vater. An approximately 10-mm hypervascular tumor at the ampulla of Vater
and a 41-mm cyst adjacent to the wall of the jejunum were revealed by abdominal computed tomography. We
performed pylorus-preserving pancreaticoduodenectomy with lymph node dissection. Macroscopic examination
revealed a 9-mm tumor of the ampulla of Vater and a 52-mm cyst adjacent to the wall of the jejunum. Histological
examination revealed that the cyst was a lymph node metastasis. The final diagnosis was non-functional NET G1 of
the ampulla of Vater, designated T1N1M0 stage IIIB. Postoperatively, the patient underwent no treatment and has
had no recurrence for 4 years.
Conclusions: This case demonstrates that sporadic NETs of Vater’s papilla have aggressive metastatic potential even
with a small primary lesion, and radical resection with lymphadenectomy is recommended for all cases.
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Background
Neuroendocrine tumors (NETs) of the ampulla of
Vater are rare [1, 2]. A total of 139 patients with NETs
of the ampulla were identified from the Surveillance,
Epidemiology, and End Results Program of the National
Cancer Institute between 1973 and 2006 [3]. The inci-
dence of NETs has been rising due to an improvement
in diagnostic techniques, and the mortality rate has also
been increasing in recent years [4, 5]. There are still
many issues regarding diagnosis and treatment.
There is no curative treatment for NETs, except surgi-
cal resection. In general, a tumor size greater than 2 cm
in diameter, invasion of the muscularis propria, and
presence of mitotic figures are correlated with metastasis
of NETs [6]. Therefore, surgery has been recommended
for tumors larger than 2 cm.
In the cases of duodenal NETs, tumors smaller than
2 cm have limited metastatic potential [7, 8]. However,
unlike NETs in other areas, it has been demonstrated
that tumor size has no correlation with metastatic
potential in NETs of the ampulla of Vater [1, 9]. Thus,
the best therapeutic approach for ampullary NETs re-
mains controversial.
Herein, we report our experience with a rare case of
9-mm ampullary NET with lymph node metastasis and
review the current literatures on the topic.
Case presentation
A 54-year-old man presented with a history of epigastric
pain and melena over the last few days. The patient did
not have hormone-related symptoms. He had received
treatment for a myocardial infarction at the age of 51
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with an antiplatelet therapy; therefore, we considered
that there was a possibility of tumor bleeding by anti-
platelet therapy. Blood biochemical examinations indi-
cated slight anemia. Serum carbohydrate antigen 19-9
and carcinoembryonic antigen (CEA) levels were not
elevated. The 24-h urinary 5-hydroxyindoleacetic acid
(5-HIAA) level was 3.2 mg. Upper gastrointestinal en-
doscopy showed a bulging papilla with bleeding (Fig. 1a).
A biopsy was not performed at that time because of the
active bleeding. Endoscopic examination on day 7 re-
vealed an approximately 10-mm mass of the ampulla of
Vater with a superficial ulcer (Fig. 1b). Pathological find-
ings of the endoscopic biopsy of the ampulla revealed a
well-differentiated NET. Immunohistochemically, the
tumor stained positive for CD56, chromogranin A, and
synaptophysin. An upper gastrointestinal series showed
an ampullary mass without any obvious lesions of the je-
junum (Fig. 1c). An enhanced abdominal computed
tomography (CT) scan revealed a 10-mm hypervascular
tumor at the ampulla of Vater and a 41-mm multilocular
cyst adjacent to the wall of the jejunum near the liga-
ment of Treitz (Fig. 2). The wall of the multilocular cyst
showed the same enhancement patterns with the tumor.
The patient underwent magnetic resonance imaging that
was negative for visceral metastasis. About the cyst, the
preoperative definitive diagnosis was not provided.
The patient was referred to our hospital for treatment
of the NET. We performed a pylorus-preserving pan-
creaticoduodenectomy with regional lymph node dissec-
tion. The operative time was 497 min, and the volume
of blood loss during the surgery was 1220 ml. The
resected specimen was macroscopically a 9-mm white
solid tumor (Fig. 3). Tumor cells confined to duodenal
mucosal layer. There was a 52-mm cyst in the superior
mesentery adjacent to the wall of the jejunum (Fig. 3).
Microscopically, the tumor consisted of small-sized
round cell proliferations with a solid nest pattern
(Fig. 4a). The cyst preserved the structure of the lymph
node and was the superior mesenteric lymph node me-
tastasis of the tumor (Fig. 4b). We performed D2 lymph
node dissection, and there was no metastatic lymph
node except for the superior mesenteric lymph node.
Immunohistochemically, the resected specimen revealed
that the tumor and the lymph node metastasis were
positive for chromogranin A (Fig. 4c) and CD56 and
negative for synaptophysin. The Ki-67-labeling index of
Fig. 1 Upper gastrointestinal endoscopy shows a bulging papilla with bleeding on day 1 (a) and shows an approximately 10-mm mass of the
ampulla of Vater with a superficial ulcer on day 7 (b). Upper gastrointestinal series shows an ampullary mass (arrow) (c)
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the tumor cells determined with MIB-1 was 2.0 %. The
final diagnosis was sporadic non-functional NET G1 of
the ampulla of Vater (pT1N1M0 stage IIIB). The patient
was discharged 36 days after the operation. He has had
no recurrence for 4 years after surgery. No further treat-
ment was administered.
Discussion
NETs of the ampulla of Vater are rare and difficult to
diagnose [1, 2]. Jaundice (60 %) and abdominal pain
(40 %) are the most frequent symptoms. Upper gastro-
intestinal bleeding is a rare presentation (<3 %) [1, 10].
In our case, the patient presented with abdominal pain
and melena. On admission, upper gastrointestinal endos-
copy revealed a bulging papilla with active bleeding.
When we performed gastric endoscopy again 7 days
later, we found a 10-mm mass of the ampulla of Vater
with a superficial ulcer.
Diagnosis of NETs is established by histological and
immunohistochemical analysis of endoscopic biopsy
specimens [11]. NETs of the ampulla of Vater usually ap-
pear as submucosal masses that are small and spherical
with a smooth surface and an intact duodenal mucosa.
Consequently, superficial biopsies are negative and dee-
per biopsies are required for a diagnosis [12, 13]. In our
present case, we could get the biopsy specimen from the
mass because it had an ulcerated surface. Thus, the cor-
rect diagnosis of a NET was established preoperatively.
However, we could not diagnose the cyst adjacent to the
wall of the jejunum as a lymph node metastasis at the
time of resection.
Previous reports have suggested that the biological be-
havior of ampullary NETs is distinct from that of duo-
denal NETs and they are more aggressive [14]. Randle
and colleagues reported that ampullary NETs were lar-
ger, higher grade, and higher stage and had a higher rate
of lymph node metastasis than duodenal NETs [15]. The
incidence of lymph node metastases in patients with
resected ampullary NETs and duodenal NETs was 72.9
and 48.4 %, respectively.
Fig. 2 Enhanced abdominal computed tomography scan shows a 10-mm hypervascular tumor at the ampulla of Vater (arrow) and a 41-mm
multilocular cyst adjacent to the wall of the jejunum near the ligament of Treitz (arrowhead)
Fig. 3 Pathological findings show a 9-mm white solid ampullary tumor (arrow) and a 52-mm cyst adjacent to the wall of the jejunum (arrowhead)
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In the case of ampullary NETs, even in tumors smaller
than 2 cm, a high percentage have lymph node metasta-
ses [14, 16–18]. Nikou et al. reported that lymph node
metastases were found in two cases of ampullary NET
with tumor sizes of 1.0 and 1.2 cm, respectively [19]. In
the present case, the histologic examination revealed
metastasis to distant lymph nodes despite the tumor
only being 9 mm in diameter and within duodenal mu-
cosal layer. These findings suggest that there is no cor-
relation between tumor size and metastatic potential in
ampullary NETs. We consider that an anatomical reason
is one of the reasons why NETs at the ampulla of Vater
have high incidence of metastasis. Ampullary carcinoma
with perisphincteric or duodenal submucosal invasion
showed more frequent lymph node metastasis and a
greater tumor recurrence rate than tumor limited within
the sphincter of Oddi muscle [20]. Moreover, the peri-
sphincteric and duodenal submucosal space is relatively
small and closer to the next layering of duodenal proper
muscle and the pancreas. Thus, the malignant potential
of perisphincteric and/or duodenal submucosal invasion
may be greater than that of other gastrointestinal tract
tumors. Moreover, previous studies have reported that
lymph node metastasis is difficult to detect on preopera-
tive imaging [18, 21]. Although some authors report the
existence of lymph node metastasis of NETs is not cor-
related with patient prognosis, this could be due to
metastasis to the liver or some other organ, which is an
important prognostic factor for NETs. Therefore, radical
resection with lymph node dissection is recommended
as a treatment of ampullary NETs regardless of tumor
size [1, 14, 18, 22, 23].
We performed a pylorus-preserving pancreaticoduode-
nectomy with regional lymph node resection and also
resected a 52-mm lymphatic metastasis adjacent to the
wall of the jejunum. Despite the lymph node involve-
ment, the Ki-67-labeling index was low (2 %) and the
patient has had no evidence of recurrence for 4 years
after surgery.
Randle et al. indicated that tumor size was correlated
with poor prognosis, but the presence of positive lymph
nodes was not a predictive outcome in resected am-
pullary NETs [15]. Untch et al. reported that only
tumor size and tumor grade were associated with re-
currence [24]. Thus, we can perform radical resection
and completely remove the tumor with good clinical
outcomes.
Conclusions
In conclusion, NETs of the ampulla of Vater, even very
small tumors (<1 cm), may have aggressive metastatic
potential. A radical resection with lymphadenectomy
might be the appropriate treatment strategy for sporadic
NETs of the ampulla of Vater.
Fig. 4 Microscopically, the tumor consists of a small-sized round cell proliferation with a solid nest pattern (a). The cyst preserved the structure of
the lymph node and was the superior mesenteric lymph node metastasis of the tumor (b). Immunohistochemically, the resected specimen
revealed that the tumor and lymph node metastases were positive for chromogranin A (c)
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